iifl-logo

Shivalik Rasayan Ltd Directors Report

430.65
(2.22%)
Oct 10, 2025|12:00:00 AM

Shivalik Rasayan Ltd Share Price directors Report

TO THE MEMBERS,

Your Directors have pleasure in presenting this Forty Seventh (47th) Annual Report together with the Audited Financial Statements and Auditors Report for the financial year ended on March 31,2025.

FINANCIAL RESULTS

(Rs. In Lakhs)

Financial Data

Standalone

Consolidated

2024-25 2023-24 2024-25 2023-24

Sales

14,922.59 9,367.63 31,177.31 27,298.25

Other Income

206.29 165.14 830.67 397.71

Profit for the year before Tax

1,352.74 1,020.75 2,340.73 2,328.30

Provision for taxation

(289.34) (186.79) (653.29) (608.48)

Deferred Tax Assets/(Liability)

323.28 29.62 354.80 93.15

Net Profit

1,386.68 863.58 2,042.25 1,812.97

COMPANYS PERFORMANCE & STATE OF COMPANYS AFFAIR

On a consolidated basis, the revenue for Financial Year 2025 was Rs. 31,177.31 Lakhs, higher by 14.20% over the previous year revenue of Rs. 27,298.25 Lakhs. The profit after tax (PAT) attributable to shareholders was Rs. 2,042.25 Lakhs in Financial Year 2025 and Rs. 1,812.97 Lakhs in Financial Year 2024, thereby registering a growth of 12.64% over the last year PAT.

On Standalone basis, the revenue for Financial Year 2025 was Rs. 14,922.59 Lakhs, higher by 59.29% over the previous year revenue of Rs. 9,367.63 Lakhs. The profit after tax (PAT) attributable to shareholders for Financial Year 2025 was Rs. 1,386.68 Lakhs registering a growth of 60.57% percent over the PAT of Rs. 863.58 Lakhs for Financial Year 2024.

RETURN OF SURPLUS FUNDS TO SHAREHOLDERS

Based on the Companys performance, the Directors have recommended a final dividend for the Financial Year 202425 on Equity Share Capital @ 10% [Rs. 0.50 Paise per equity share (nominal face value of Rs. 5/- each)]. The Dividend payout is subject to approval of shareholders in ensuing Annual General Meeting.

ASSOCIATE COMPANY Medicamen Biotech Limited (MBL)

During 2024-25, SRL has purchased 21,000 Equity Shares of its Associate Company, Medicamen Biotech Limited from open market thereby increasing its stake to 43.16%.

Also, the report on the performance and financial position of its associate and salient features of their Financial Statements in the prescribed Form AOC-1 is annexed to this report as Annexure "A"

Further, pursuant to the provisions of Section 136 of the Act, the financial statements of the Company & consolidated financial statements along with relevant documents are available on the website of the Company i.e. www. shivalikrasayan.com

UTILIZATION OF FUNDS

During the year the Company has received funds for the conversion of 1,90,000 Warrants into Equity Shares which was issued at a price of Rs. 716/- per share to the persons belonging Non- Promoter Category for creating a separate facility in its existing Active Pharmaceutical Ingredient (API) plant at Dahej-II to manufacture Diabetology and Cardiovascular APIs for Domestic Market.

RESERVES

The Board of Directors has decided to retain the entire amount of profits for 2024-25 in the retained earnings.

DEPOSITS

The Company has not accepted any deposits from public and as such, no amount on account of principal or interest on deposits from public was outstanding as on the date of the balance sheet.

DIRECTORS AND KEY MANAGERIAL PERSONNEL

Mr. Rahul Bishnoi and Mr. Ashwani Kumar Sharma retires by rotation and being eligible, offers themselves for reappointment. A resolution seeking shareholders approval for their re-appointment forms part of the Notice.

Pursuant to the provisions of Section 149 of the Act, the Independent Directors have submitted declarations that each of them meet the criteria of independence as provided in Section 149(6) of the Act along with Rules framed thereunder

and Regulation 16(1)(b) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ("SEBI Listing Regulations"). There has been no change in the circumstances affecting their status as Independent Directors of the Company.

During the year the term of Mr. Harish Pande, Mr. Arun Kumar and Mr. Kailash Gupta as an Independent Directors were completed and in place Mr. Sham Goel, Mr. Ramit Madan and Mr. Shaival Saurabh based on the recommendation of Nomination and Remuneration Committed were appointed as an Independent Directors of the Company. These appointments were approved by the shareholders of the Company by way of Special resolution at its Annual General Meeting held on September 28, 2024.

Also, during the year under review and based on the recommendation of Nomination and Remuneration Committee, Dr. Ravi Kumar Bansal was further re-appointed for a second term of 5 years as an Independent Director of the Company by way of special resolution at its Annual General Meeting held on September 28, 2024.

Pursuant to the provisions of Section 203 of the Act, the Key Managerial Personnel of the Company as on March 31, 2025 are: Mr. Suresh Kumar Singh, Vice- Chairman & Whole- Time Director, Dr. Vimal Kumar Shrawat, Managing Director, Mr. Vinod Kumar, Chief Financial Officer and Ms. Parul Choudhary, Company Secretary.

NUMBER OF MEETINGS OF THE BOARD

Five (5) meetings of the Board were held during the year. For details of meetings of the Board, please refer to the Corporate Governance Report, which is a part of this report.

Committees of the Board

As on March 31, 2025, the Board has 5 (Five) Committees. Audit Committee, Nomination and Remuneration Committee, Stakeholders Relationship Committee, Risk Management Committee, and Corporate Social Responsibility Committee. The details pertaining to the meetings and composition of the Committees of the Board are included in the Corporate Governance Report, which forms part of this Report.

DIRECTORS RESPONSIBILITY STATEMENT

Pursuant to Section 134(5) of the Act, the Board of Directors, to the best of its knowledge and ability, confirm that:

a) i n the preparation of the Annual Financial Statements for the year ended on March 31, 2025 the applicable accounting standards have been followed.

b) the Company have selected such accounting policies and applied them consistently and made judgment and

estimates that were reasonable and prudent so as to give a true and fair view of the state of affairs of the Company at the end of the financial year and of the profit of the Company for the year under review.

c) they have taken proper and sufficient care for the maintenance of adequate accounting records in accordance with the provisions of the Companies Act, 2013 for safeguarding the assets of the Company and for preventing and detecting fraud and other irregularities.

d) the annual financial statements have been prepared on a on-going concern basis.

e) the proper Internal Financial Controls were in place and that the financial controls were adequate and were operating effectively.

f) the systems to ensure compliance with the provisions of all applicable laws were in place and were adequate and operating effectively.

BOARD EVALUATION

Pursuant to the applicable provisions of the Act and the SEBI Listing Regulations, the Board has carried out an annual evaluation of its own performance, performance of the Directors as well as the evaluation of the working of its Committees. The NRC has defined the evaluation criteria, procedure and time schedule for the Performance Evaluation process for the Board, its Committees and Directors.

The performance of the Board and individual Directors was evaluated by the Board after seeking inputs from all the Directors. The performance of the Committees was evaluated by the Board after seeking inputs from the Committee Members.

The criteria for performance evaluation of the Board included aspects such as Board composition and structure, effectiveness of Board processes, contribution in the longterm strategic planning, etc. The criteria for performance evaluation of the Committees included aspects such as structure and composition of Committees, effectiveness of Committee Meetings, etc. The above criteria are broadly based on the Guidance Note on Board Evaluation issued by the Securities and Exchange Board of India.

The Chairman of the Board had one-on-one meetings with each Independent Director and the Chairman of the NRC had one-on-one meetings with the Executive and Non-Executive, Non-Independent Directors.

The Board discussed upon the performance evaluation outcome and concluded that they were satisfied with the overall performance of the Board and Committees of the

Board and Directors individually. The Board also assessed the fulfilment of the independence criteria by the Independent Directors of the Company and their independence from the management as specified in the Listing Regulations.

ln a separate Meeting, the Independent Directors evaluated the performance of Non-Independent Directors and performance of the Board as a whole. They also evaluated the performance of the Chairman taking into account the views of the Managing Director and Non-Executive Directors as well.

FAMILIARIZATION PROGRAM FOR THE INDEPENDENT DIRECTORS

In compliance with the requirements of Regulation 25(7) of the Listing Regulations, the Company has put in place a Familiarization Program for the Independent Directors to familiarize them with the Company, their roles, rights, responsibilities in the Company, nature of the industry in which the Company operates, business model etc. The details of the Familiarization Program are available on the website of the Company at https://shivalikrasayan.com/srl- policies/

POLICY ON DIRECTORS APPOINTMENT AND REMUNERATION AND OTHER DETAILS

The Companys policy on appointment of Directors is available on the Companys website at www.shivalikrasayan . com. The policy on remuneration and other matters provided in Section 178(3) of the Act has been disclosed in the Corporate Governance Report, which is a part of this report and is also available on the Companys website at https:// shivalikrasayan.com/srl-policies/

INTERNAL FINANCIAL CONTROL

The Companys internal financial controls framework is based on the "three (3) lines of defence model". The Company has laid down Standard Operating Procedures, policies and authorities to guide the operations of the business. Process owners are responsible for ensuring compliance with the policies and procedures laid down by the management. Robust and continuous internal monitoring mechanisms ensure timely identification of risks and issues. The statutory and internal auditors undertake rigorous testing of the control environment of the Company.

The Audit Committee reviews the adequacy and effectiveness of the Companys internal controls environment and monitors the implementation of the audit recommendations including those relating to strengthening of the Companys risk management policies and systems. The ultimate objective being a zero-surprise risk-controlled organization.

These internal financial controls help to put in place checks on the implementation of the internal financial controls, policies and procedures that are adopted by the Company for ensuring an orderly and efficient conduct of its business. These internal financial controls help in safeguarding assets, prevention and detection of frauds and/or errors, maintaining the accuracy and completeness of the accounting records.

AUDITORS

a. Statutory Auditors- At the Forty Fifth (45th) Annual General Meeting held on September 29, 2023 appointed M/s Rahul Chaudhary & Associates, Chartered Accountants (Registration Number 033971N) as Statutory Auditors of the Company till the conclusion of Fiftieth (50th) AGM.

The report of the Statutory Auditor forms part of the Integrated Report and Annual Accounts for 2024-25. The said report does not contain any qualification, reservation, adverse remark or disclaimer. During the year under review, the Statutory Auditors did not report any matter under Section 143(12) of the Act, therefore no detail is required to be disclosed under Section 134(3)(ca) of the Act.

b. Secretarial Auditor-The Board of Directors of your Company has appointed M/s AMJ & Associates, Company Secretaries, Delhi as Secretarial Auditor pursuant to the provisions of Section 204 of the Companies Act, 2013. The Report of the Secretarial Auditor is annexed to the Report as per Annexure "B".

In accordance with the SEBI Listing Regulations, the Board of the Company has appointed. M/s. AMJ & Associates, a Peer reviewed firm, as the Secretarial Auditors of the Company for conducting Secretarial Audit and issue the Secretarial Audit Report for a term of consecutive five (5) years from Financial Year April 01,2025 to March 31,2030, subject to the approval of the Members of the Company at the ensuing Annual General Meeting.

c. Internal Auditor- The Board of Directors of your Company has appointed M/s, Amar Sharma & Co., Chartered Accountants New Delhi as Internal Auditors pursuant to the provisions of Section 138 of the Companies Act, 2013 for the financial year 2025-26..

d. Cost Auditors- The Board of Directors of the Company has, on the recommendation of the Audit Committee, approved the appointment of M/s Cheena & Associates as the Cost Auditors of the Company.

In accordance with the provisions of Section 148(3) of the Act read with Rule 14 of the Companies (Audit and Auditors)

Rules, 2014, as amended, the remuneration of Rs. 75,000/- plus applicable taxes and reimbursement of out-of-pocket expenses payable to the Cost Auditors as recommended by the Audit Committee and approved by the Board has to be ratified by the Members of the Company. Accordingly, a resolution to this effect forms part of the Notice convening the AGM.

CORPORATE GOVERNANCE

The Governance, Corporate Secretarial and Legal functions of the Company ensure maintenance of good governance within the organization. They assist the business in functioning smoothly by ensuring compliance and providing strategic business partnership in the areas including legislative expertise, corporate restructuring, regulatory changes and governance. The Company has also adopted the governance guidelines on Board effectiveness to fulfill its responsibility towards its stakeholders.

A report on Corporate Governance together with Auditors certificate confirming compliance with Corporate Governance norms, as stipulated under SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 forms a part of this report along with Report on Management Discussion and Analysis as Annexure "C".

ANNUAL RETURN

Pursuant to Section 92(3) read with Section 134(3)(a) of the Act, the Annual Return as on March 31,2025 is available on https://shivalikrasayan.com/annual-reports/

RISK MANAGEMENT

The Company has a comprehensive Risk Management framework that seeks to minimize the adverse impact on business objectives and capitalize on opportunities. The Company has implemented a mechanism for risk management and formulated a Risk Management Policy that is reviewed in line with the SEBI Listing Regulations framework. The Risk Management Policy was reviewed and amended during the year. The Policy provides for identification of risks and formulating mitigation plans. Major risks identified by business and other functions are systematically addressed through mitigation actions on a continuous basis.

The Risk Management Committee, chaired by an Independent Director, monitors the risks and their mitigation actions as well as formulating strategies towards identifying new and emergent risks.

Further, the Board is apprised of any actual/emergent risk that may threaten or\ impact the long-term plans of the Company. Such risks are linked to the audit universe and are also covered as a part of the annual risk-based audit plan.

The risk appetite of the organization is approved by the RMC and the Board and is aligned to the Vision of the organization. It is an important metric for governing all business actions and strategic decisions. The Risk appetite is driven by the following:

• Health and safety of our employees and the communities in which we operate are our prime concern and our operating strategy is focused on the above objective;

• Management actions are focused on continuous improvement;

• Environment and Climate Change impacts are assessed on a continuous basis and business decisions support systems including capital allocation, considers climate impact through the internal carbon pricing framework;

• The long-term strategy of the Company is focused on generating profitable growth and sustainable cash flows that creates long term stakeholder value

The Audit Committee has additional oversight in the area of financial risks and controls. The major risks identified by the businesses and functions are systematically addressed through mitigating actions on a continuing basis.

WHISTLE BLOWER POLICY/ VIGIL MECHANISM

The Company maintains a robust Whistleblower Policy that ensures transparency and accountability. Whistleblowers are granted direct access to the Chairperson of the Audit Committee should they wish to report any concerns related to unethical behavior, improper practices, fraud, or violations of laws, rules, or regulations.

There have been no instances where individuals have been denied access to the Chairperson for reporting such concerns. All cases reported under the Whistleblower Policy are presented to and reviewed by the Audit Committee.

The Company has a Whistle Blower Policy and has established the necessary vigil mechanism for Directors and Employees in confirmation with Section 177(9) of the Act and Regulation 22 of Listing Regulations, to report concerns about unethical behavior. The details of the policy have been disclosed in the Corporate Governance Report, which is a part of this report and is also available on https:// shivalikrasayan.com/srl-policies/

BUSINESS RESPONSIBILITY AND SUSTAINABILITY REPORT

The Company is committed to addressing the needs of the communities in which it operates, thereby maximizing societal value. Additionally, it conducts its business in a manner that generates a positive impact and enhances stakeholder value.

As per SEBI Listing Regulations, the Corporate Governance Report and the integrated Management Discussion and Analysis, the Business Responsibility and Sustainability Report ("BRSR") form part of the Directors Report as Annexure "D".

PARTICULARS OF EMPLOYEES

Disclosures pertaining to remuneration and other details as required under Section 197(12) of the Act read with Rule 5(1) of the Companies (Appointment and Remuneration of Managerial Personnel) Rules, 2014 are provided as per Annexure "E".

In terms of the provisions of Section 197(12) of the Act, read with Rules 5(2) and 5(3) of the Companies (Appointment and Remuneration of Managerial Personnel) Rules, 2014, a statement showing the names and other particulars of employees drawing remuneration in excess of the limits as set out in the said Rules forms part of this report.

SIGNIFICANT AND MATERIAL ORDERS PASSED BY THE REGULATORS OR COURTS

There are no significant, material orders passed by the Regulators or Courts, which would impact the going concern status of the Company and its future operations.

TRANSACTION WITH RELATED PARTIES

The Company has formulated a Policy on Related Party Transactions in accordance with the Act and the SEBI Listing Regulations including any amendments thereto for identifying, reviewing, approving and monitoring of Related Party Transactions (RPTs).

During the year under review, the RPT Policy was amended and the said Policy is available on the Companys website at https://shivalikrasayan.com/srl-policies/

All RPTs are presented to the Audit Committee for review and approval. Prior omnibus approval of the Audit Committee is obtained on periodic basis for the transactions which are planned/ repetitive in nature. A statement giving details of all RPTs entered pursuant to omnibus approval so granted is placed before the Audit Committee on a quarterly basis for its review.

The RPTs entered into during the year under review were on arms length basis, in the ordinary course of business and were in compliance with the applicable provisions of the Act read with the Rules framed thereunder and the SEBI Listing Regulations. Further, the Company did not enter into any contracts or arrangements with related parties in terms of Section 188(1) of the Act and no material related party transactions were entered into during the year under review.

In terms of Regulation 23 of the SEBI Listing Regulations, the Company submits details of RPTs as per the prescribed format to the stock exchanges on a half-yearly basis.

The information on transactions with related parties pursuant to Section 134(3)(h) of the Act read with Rule 8(2) of the Companies (Accounts) Rules, 2014 are given in Annexure "F" in Form no AOC-2 and the same forms part of this report.

PARTICULARS OF LOANS, GUARANTEES AND INVESTMENTS

During the year under review, the Company has not made any investment. Further, the Company has not given any loan or corporate guarantee or provided any security during the year.

Details of loans, guarantees and investments covered under the provisions of Section 186 of the Act are given in the notes to the Financial Statements.

CORPORATE SOCIAL RESPONSIBILITY

The brief outline of the Corporate Social Responsibility (CSR) policy of the Company and the initiatives undertaken by the Company on CSR activities during the year under review are set out in Annexure "G" of this report in the format prescribed in the Companies (Corporate Social Responsibility Policy) Rules, 2014. For other details regarding the CSR Committee, please refer to the Corporate Governance Report, which is a part of this report. The CSR policy is available on https:// shivalikrasayan.com/srl-policies/

MATERIAL CHANGES AND COMMITMENTS, IF ANY, AFFECTING THE FINANCIAL POSITION OF THE COMPANY, HAVING OCCURRED SINCE THE END OF THE YEAR AND TILL THE DATE OF THE REPORT

There have been no material changes and commitments, which affect the financial position of the Company which have occurred between the end of the financial year to which the financial statements relate and the date of this Report.

SEXUAL HARASSMENT OF WOMEN AT WORKPLACE

There were no incidences of sexual harassment reported during the year under review, in terms of the provisions of the Sexual Harassment of Women at Workplace (Prevention, Prohibition and Redressal) Act, 2013.

ENERGY CONSERVATION, TECHNOLOGY ABSORPTION AND FOREIGN EXCHANGE EARNINGS AND OUTGO

The information regarding Conservation of Energy, Technology Absorption and Foreign Exchange Earnings and Outgo stipulated under Section 134(3)(m) of the Companies Act, 2013 read with the Rule, 8 of the Companies (Accounts) Rules, 2014.

a) CONSERVATION OF ENERGY

We remain committed to reducing our environmental footprint. Prevention of the wasteful use of natural resources, consumption of water and energy, and the management of waste and hazardous materials have been the key enablers in our journey of environmental sustainability. We have embarked on a critical review of all our approaches towards energy and environmental conservation that will help us identify goals and action plans for the longer term.

b) TECHNOLOGY ABSORPTION/RESEARCH AND DEVELOPMENT

1. During the year under review your Company has installed Scrubber at Dahej Unit-II to mitigate the effect of vapours in atmosphere. It sucks the Chemical Vapours and scrubs these vapours before releasing into air to protect the environment from chemical process.

2. Capital Expenditure is included in Fixed Assets and Capital Work in Progress and depreciation is provided at the respective applicable rates.

3. Expenditure incurred on R&D are as below:

Particulars

2024-25 2023-24

Capital Expenditure

52.92 43.82

Revenue Expenditure

614.52 659.08

Total

667.44 702.90

c) FOREIGN EXCHANGE EARNING AND OUTGO

Value of Imports & Exports in Foreign Currency

Particulars

As at March 31, 2025 As at March 31, 2024

Raw Materials

692.04 358.15

(on CIF Basis)

Value of Exports

12.40 24.79

(Calculation on FOB basis)

ACKNOWLEDGEMENT

The Directors deeply appreciate and value the dedication, support, hard work, and commitment of all employees. Their continuous efforts in improving all functions and areas, along with the efficient utilization of the Companys resources, have been instrumental in achieving sustainable and profitable growth.

The Directors would also like to place on record their appreciation for the continued co-operation and support received by the Company during the year from bankers, financial institutions, Government authorities, farming community, business partners, shareholders, customers and other stakeholders. The Directors look forward to continuance of the supportive relations and assistance in the future.

Annexure- "A"

FORM NO. AOC-1

Statement containing salient features of the financial statement of Subsidiaries/Associate Companies/Joint Ventures (Pursuant to first proviso to sub-section (3) of section 129 read with rule 5 of Companies (Accounts) Rules, 2014)

Part "A": Subsidiaries

(Information in respect of each subsidiary to be presented with amounts in Rs.)- NA

1. S. No.

2. Name of the subsidiary-

3. Reporting period for the subsidiary concerned, if different from the holding companys reporting period-

4. Reporting currency and Exchange rate as on the last date of the relevant financial year in the case of foreign subsidiaries.

5. Share capital-

6. Reserves Lakhs& surplus-

7. Total assets-

8. Total Liabilities-

9. Investments-

10. Turnover-

11. Profit before taxation-

12. Provision for taxation-

13. Profit after taxation-

14. Proposed Dividend-

15. % of shareholding-

Notes: The following information shall be furnished at the end of the statement:

1. Names of subsidiaries which are yet to commence operations- NA

2. Names of subsidiaries which have been liquidated or sold during the year.- NA Part "B": Associates and Joint Ventures

Statement pursuant to Section 129 (3) of the Companies Act, 2013 related to Associate Companies and Joint Ventures

Name of Associates/Joint Ventures

Medicamen Biotech Limited

Latest audited Balance Sheet Date

March 31,2025

No. Shares of Associate/Joint Ventures held by the Company at the year end

54,87,095

Amount of Investment in Associates/Joint Venture

Rs. 74,46,62,944/-

Extend of Holding %

43.16

Description of how there is significant influence

The Board controls the full affairs of the Company, moreover it acquires 43.16% stake in its Associate Company

Reason why the associate/joint venture is not consolidated

NA

Net worth attributable to Shareholding as per latest audited Balance Sheet

Rs. 217,63,77,000/-

Profit / Loss for the year

Rs. 9,44,75,000/-

i. Considered in Consolidation

i. Not Considered in Consolidation

1. Names of associates or joint ventures which are yet to commence operations. NA

2. Names of associates or joint ventures which have been liquidated or sold during the year. NA

SECRETARIAL AUDIT REPORT Form No. MR-3

For the Financial Year ended March 31, 2025

Pursuant to section 204(1) of the Companies Act, 2013 and rule 9 of the Companies ( Appoint and Remuneration of Managerial Personnel) Rules, 2014]

To,

The Members,

SHIVALIK RASAYAN LIMITED,

Kolhupani, PO. Chandanwari,

Dehradun- 248007

We have conducted the secretarial audit of the compliance of applicable statutory provision and the adherence to good corporate practice by SHIVALIK RASAYAN LIMITED (hereinafter called the Company). Secretarial Audit was conducted in a manner that provided us a reasonable basis for evaluating the corporate conducts/statutory compliances and expressing my opinion thereon.

Based on our verification of the SHIVALIK RASAYAN LIMITED books, papers, minute books, forms and returns filed and other records maintained by the Company and also the information provided by the Company, its officers, agents and authorized representative during the conduct of secretarial audit, We hereby report that in our opinion, the Company has during the audit period covering the financial year ended on March 31, 2025 (Audit Period) complied with the statutory provision listed hereunder and also that the Company has proper Board processes and compliance mechanism in place to the extent, in the manner and subject to the reporting made hereinafter:

We have examined the books, papers, minute books, forms and returns filed and other records maintained by SHIVALIK RASAYAN LIMITED ("the Company") for the financial year ended on March 31,2025 according to the provisions of:

a. The Companies Act 2013 (The Act) and the rules made thereunder;

b. The Securities Contract (Regulation) Act, 1956 (SCRA) and the Rules made thereunder;

c. The Depository Act, 1996 and the Regulations and Byelaws framed thereunder;

d. Foreign Exchange Management Act, 1999 and the rules and regulations made thereunder to the extent of Foreign Direct Investment, Overseas Direct Investment and External Commercial Borrowings;

e. The following Regulation and Guidelines prescribed under the Securities Exchange Board of India Act, 1992 (SEBI Act):-

(a) The Securities and Exchange Board of India

(Substantial Acquisition of Shares and Takeovers) Regulation 2011;

(b) The Securities and Exchange Board of India

(Prohibition of Insider Trading) Regulations, 1992;

(c) The Securities and Exchange Board of India

(Issue of Capital and Disclosure Requirements) Regulations, 2018;

(d) The Securities and Exchange Board of India

(Share Based Employee Benefits and Sweat Equity Share) Regulations, 2021; (Not applicable to the Company during the audit period)

(e) The Securities and Exchange Board of India

(Issue and Listing of Non-Convertible Securities) Regulation, 2021; (Not applicable to the Company during the audit period)

(f) The Securities and Exchange Board of India (Registrars to an Issue and Share Transfer Agents) Regulation, 1993 regarding the Companies Act and dealing with client;

(g) Securities and Exchange Board of India (Delisting of Equity Shares) Regulations, 2021; (Not applicable to the Company during the audit period) and

(h) The Securities and Exchange Board of India (Buyback of Securities) Regulations 2018; (Not applicable to the Company during the audit period)

We have examined compliance with the applicable clauses of the following:

(a) Secretarial Standards issued by The Institute of Company Secretaries of India on Meetings of the Board of Directors and General Meeting.

(b) The Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.

i. Other laws specifically applicable to the Company, as identified and compliance whereof confirmed by the management of the Company:- The Factories Act, 1948

- The Insecticides Act,1968

- The Environment Protection Act,1986

- The Indian Boilers Act,1923

We have also examined compliance with the applicable clauses of the following:

(a) Secretarial Standard issued by The Institute of Company Secretaries of India.

(b) The Listing Agreement Entered into by the Company with Stock Exchanges read with the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

We report that during the Audit Period, the Company has confirmed compliance with the provisions of the above- mentioned applicable laws.

During the period under review the Company has generally complied with the provisions of the Act, Rules, Regulations, Guidelines, Standards, etc. mentioned above We further report that The Board of Directors of the Company is duly constituted with proper balance of Executive Directors, Non-Executive Directors and Independent Directors. The changes in composition of the Board of Directors that took place during the period under review were carried out in compliance with provisions of the Act.

Adequate notice is given to all the directors to schedule the Board and Meetings, agenda and detailed notes on agenda were sent at least seven days in advance and a system exists for seeking and obtaining further information and clarifications on the agenda item before the meeting and for meaningful participation at the meeting.

All decision at Board Meetings and Committee Meetings are carried out unanimously as recorded in the minutes of the meetings of the Board of Directors or Committee of the Board, as the case may be.

We further report that there are adequate systems and processes in the Company commensurate with the size and operations of the Company to monitor and ensure compliance with applicable laws, rules, regulations and guidelines.

We further report that during the audit period the Company has

- During the Year Mr. Harish Pande (DIN: 01575625), Mr. Arun Kumar (DIN: 07031730) and Mr. Kailash Gupta (DIN: 00147440), ceased to be an Independent Directors of the Company upon completion of 2 consecutive terms of 5 years each on August 13, 2024.

- In the Board Meeting Dated August 13, 2024 the Board of DirectorsoftheCompanyhasappointedMr.RamitMadan (DIN: 08071919), Mr. Sham Goel (DIN: 02183287) and Mr. Shaival Saurabh (DIN: 01971944) as an Independent Directors of the Company for the first term of five Consecutive years commencing from August 13, 2024 which were subsequently approved by the Members of the Company in 46th AGM of the Company held on September 28, 2024.

- The Board of Directors of the Company at their meeting held on March 27, 2025, approved the allotment of 1,90,000 Equity Shares of face value of Rs.5/- each pursuant to the conversion of 1,90,000 Fully Convertible Warrants (Warrants), issued as on September 29, 2023, at an issue price of Rs.716/- each to Specified persons, by way of preferential allotment on a private placement basis and Consequent to the said allotment, the Paid-up Equity Share Capital of the Company stands increased to Rs.7,87,51,825/- divided into 1,57,50,365 Equity Shares of face value of Rs.5/- each.

This report is to be read with our letter of even date which is annexed as Annexure B-1 and form an integral part of this report.

ANNEXURE B-1

To,

The Members,

SHIVALIK RASAYAN LIMITED,

Kolhupani, PO. Chandanwari,

Dehradun- 248007

Our report of even date is to be read along with this letter.

1. Maintenance of Secretarial record is the responsibility of the management of the Company. Our responsibility is to express an opinion on these secretarial records based on our audit.

2. We have followed the audit practices and processes as were appropriate to obtain reasonable assurance about the correctness about the contents of the Secretarial records. The verification was done on test basis to ensure that correct facts are reflected in secretarial records. We believe that the process and practices, we followed provide a reasonable basis for our opinion.

3. We have relied on the Statutory Auditors for the period under review, hence we have not verified correctness and appropriateness of financial record and Books of Accounts of the Company.

4. Where ever required, we have obtained the Management representation about the compliance of laws, rules and regulations and happening of events etc.

5. The compliance of the provisions of Corporate and other applicable laws, rules, regulations, standards, is the responsibility of Management. Our examination was limited to the verification of procedures on test basis.

6. The Secretarial Audit report is neither an assurance as to the future viability of the Company nor of the efficacy or effectiveness with which the Management has conducted the affairs of the Company.

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.